News for Pediatric Healthcare Providers From the Food and Drug Administration

Marcia L. Buck, PharmD, FCCP, FPPAG, BCPPS


Pediatr Pharm. 2018;24(4) 

In This Article


The FDA approved significantly more drugs in 2017 than in previous years. With the wealth of NDAs currently under evaluation, it is likely that 2018 will see the release of another large group of important additions to the market. While most new drug approvals will likely be for use in adults only, the success of FDA incentives to stimulate pediatric research continues to add to the number of drugs with pediatric indications.